Deceptive Advertising! Claims Novo in GLP-1 Lawsuit Fallout
Two pharmaceutical giants are in court over GLP-1 advertising. This tangle could redefine how GLP-1s are marketed and...
Stock indices exist to track market performance and guide investment decisions. Learn their purpose, construction, and practical uses.
22,537 articlesTwo pharmaceutical giants are in court over GLP-1 advertising. This tangle could redefine how GLP-1s are marketed and...
Hims & Hers beat quarterly EPS but trimmed full-year guidance, extending a slide in its stock as regulatory headwinds...
When CPSS releases its earnings, it can move the stock and shape investor sentiment for months. This guide breaks dow...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Capricor is at a crossroads as 2026 earnings season unfolds. This article breaks down what to look for in capricor (c...
A high-stakes exit valued at about $5.5 million and a difficult first quarter have investors re-evaluating risk in bi...
A clear, actionable preview of ABM's Q2 2026 results. Learn what the (abm) 2026 earnings call could reveal about reve...
Robinhood is expanding beyond simple stock trading into crypto, cash management, and other financial services. This a...
As oil markets swing, Noble and Transocean stand out in the offshore drilling arena. This guide breaks down which off...
A practical guide to understanding First Solar's 2025 earnings journey. Learn what drives profits, how to read the gu...
Oracle just posted best quarter in years, powered by cloud and AI demand. This article breaks down what changed, why ...
JPMorgan downgraded Wix.com to Underweight and cut its price target to $91, citing slower core growth and volatile ma...